Canterbury DHB
This is a paediatric protocol that is widely used for the AYA group of patients that are treated in haematology. Toxicity and dose modifications information all included.
AALL1732 AMD5 Inotuzumab Ozogamicin for Newly Diagnosed HR B-ALL
Topic Code: 1178374